-+ 0.00%
-+ 0.00%
-+ 0.00%

Rapport Therapeutics CFO Troy A. Ignelzi Reports Purchase of $143,550 in Common Shares

PUBT·10/21/2026 21:47:48
Listen to the news
Rapport Therapeutics CFO Troy A. Ignelzi Reports Purchase of $143,550 in Common Shares
  • Rapport Therapeutics Chief Financial Officer Troy A. Ignelzi purchased 5,500 shares of common stock at $26.1 per share.
  • The purchase increased his directly owned holdings to 15,500 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rapport Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-428018), on October 21, 2026, and is solely responsible for the information contained therein.